Table of Content

Part 1. Introduction
1.1 Market Definition
1.2 Key Benefit
1.3 Market Segment
Part 2. Methodology
2.1 Primary
2.2 Secondary
Part 3. Executive Summary

Part 4. Market Overview
4.1 Introduction
4.2 Market Size and Forecast
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.4 Impact of COVID-19 Pandemic

Part 5. Global Market for Stem Cell Umbilical Cord Blood by Storage Service
5.1 Hybrid Cord Blood Banks
5.1.1 Market Size and Forecast
5.2 Private Cord Blood Banks
5.2.1 Market Size and Forecast
5.3 Public Cord Blood Banks
5.3.1 Market Size and Forecast

Part 6. Global Market for Stem Cell Umbilical Cord Blood by Therapeutics
6.1 Blood Diseases
6.1.1 Market Size and Forecast
6.2 Cancer
6.2.1 Market Size and Forecast
6.3 Diabetes
6.3.1 Market Size and Forecast
6.4 Metabolic Disorders
6.4.1 Market Size and Forecast
6.5 Others
6.5.1 Market Size and Forecast

Part 7. Global Market for Stem Cell Umbilical Cord Blood by Application
7.1 Regenerative Medicine
7.1.1 Market Size and Forecast
7.2 Transplant Medicine
7.2.1 Market Size and Forecast
7.3 Others
7.3.1 Market Size and Forecast

Part 8. Global Market for Stem Cell Umbilical Cord Blood by Region
8.1 Asia-Pacific
8.1.1 Market Size and Forecast
8.2 Europe
8.2.1 Market Size and Forecast
8.3 North America
8.3.1 Market Size and Forecast
8.4 Middle East And Africa (Mea)
8.4.1 Market Size and Forecast
8.5 South America
8.5.1 Market Size and Forecast

Part 9. Key Competitor Profiles
9.1 China Cord Blood Corporation
9.2 Cordlife Group Limited
9.3 Cryo-Cell International, Inc.
9.4 Esperite N.V.
9.5 MEDIPOST Co., Ltd.
9.6 ViaCord LLC
9.7 Vita 34 International
*LIST IS NOT EXHAUSTIVE

Part 10. Patent Analysis
10.1 Patent Statistics
10.2 Regional Analysis
10.3 Trends Analysis

DISCLAIMER
ABOUT GEN CONSULTING COMPANY